Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
25,125
archived clinical trials in
Diabetes

Growth and Development Study of Alglucosidase Alfa.
A Long-term Study to Evaluate Growth and Development Outcomes in Patients With Infantile-Onset Pompe Disease Who Are Receiving Alglucosidase Alfa.
Status: Enrolling
Updated:  10/26/2015
Clinical Research Facility
163
mi
from 43215
Detroit, MI
Growth and Development Study of Alglucosidase Alfa.
A Long-term Study to Evaluate Growth and Development Outcomes in Patients With Infantile-Onset Pompe Disease Who Are Receiving Alglucosidase Alfa.
Status: Enrolling
Updated: 10/26/2015
Clinical Research Facility
163
mi
from 43215
Detroit, MI
Click here to add this to my saved trials
An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 Diabetes
A Multinational Observational Study Assessing Insulin Use: Understanding the Challenges Associated With Progression of Therapy - The MOSAIc Type 2 Diabetes Study
Status: Enrolling
Updated:  10/26/2015
Clinical Research Facility
622
mi
from 43215
Little Rock, AR
An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 Diabetes
A Multinational Observational Study Assessing Insulin Use: Understanding the Challenges Associated With Progression of Therapy - The MOSAIc Type 2 Diabetes Study
Status: Enrolling
Updated: 10/26/2015
Clinical Research Facility
622
mi
from 43215
Little Rock, AR
Click here to add this to my saved trials
An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 Diabetes
A Multinational Observational Study Assessing Insulin Use: Understanding the Challenges Associated With Progression of Therapy - The MOSAIc Type 2 Diabetes Study
Status: Enrolling
Updated:  10/26/2015
Clinical Research Facility
792
mi
from 43215
Orlando, FL
An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 Diabetes
A Multinational Observational Study Assessing Insulin Use: Understanding the Challenges Associated With Progression of Therapy - The MOSAIc Type 2 Diabetes Study
Status: Enrolling
Updated: 10/26/2015
Clinical Research Facility
792
mi
from 43215
Orlando, FL
Click here to add this to my saved trials
An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 Diabetes
A Multinational Observational Study Assessing Insulin Use: Understanding the Challenges Associated With Progression of Therapy - The MOSAIc Type 2 Diabetes Study
Status: Enrolling
Updated:  10/26/2015
Clinical Research Facility
933
mi
from 43215
Wellington, FL
An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 Diabetes
A Multinational Observational Study Assessing Insulin Use: Understanding the Challenges Associated With Progression of Therapy - The MOSAIc Type 2 Diabetes Study
Status: Enrolling
Updated: 10/26/2015
Clinical Research Facility
933
mi
from 43215
Wellington, FL
Click here to add this to my saved trials
An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 Diabetes
A Multinational Observational Study Assessing Insulin Use: Understanding the Challenges Associated With Progression of Therapy - The MOSAIc Type 2 Diabetes Study
Status: Enrolling
Updated:  10/26/2015
Clinical Research Facility
403
mi
from 43215
Canton, GA
An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 Diabetes
A Multinational Observational Study Assessing Insulin Use: Understanding the Challenges Associated With Progression of Therapy - The MOSAIc Type 2 Diabetes Study
Status: Enrolling
Updated: 10/26/2015
Clinical Research Facility
403
mi
from 43215
Canton, GA
Click here to add this to my saved trials
An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 Diabetes
A Multinational Observational Study Assessing Insulin Use: Understanding the Challenges Associated With Progression of Therapy - The MOSAIc Type 2 Diabetes Study
Status: Enrolling
Updated:  10/26/2015
Clinical Research Facility
318
mi
from 43215
Crystal Lake, IL
An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 Diabetes
A Multinational Observational Study Assessing Insulin Use: Understanding the Challenges Associated With Progression of Therapy - The MOSAIc Type 2 Diabetes Study
Status: Enrolling
Updated: 10/26/2015
Clinical Research Facility
318
mi
from 43215
Crystal Lake, IL
Click here to add this to my saved trials
An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 Diabetes
A Multinational Observational Study Assessing Insulin Use: Understanding the Challenges Associated With Progression of Therapy - The MOSAIc Type 2 Diabetes Study
Status: Enrolling
Updated:  10/26/2015
Clinical Research Facility
933
mi
from 43215
North Platte, NE
An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 Diabetes
A Multinational Observational Study Assessing Insulin Use: Understanding the Challenges Associated With Progression of Therapy - The MOSAIc Type 2 Diabetes Study
Status: Enrolling
Updated: 10/26/2015
Clinical Research Facility
933
mi
from 43215
North Platte, NE
Click here to add this to my saved trials
An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 Diabetes
A Multinational Observational Study Assessing Insulin Use: Understanding the Challenges Associated With Progression of Therapy - The MOSAIc Type 2 Diabetes Study
Status: Enrolling
Updated:  10/26/2015
Clinical Research Facility
1938
mi
from 43215
Reno, NV
An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 Diabetes
A Multinational Observational Study Assessing Insulin Use: Understanding the Challenges Associated With Progression of Therapy - The MOSAIc Type 2 Diabetes Study
Status: Enrolling
Updated: 10/26/2015
Clinical Research Facility
1938
mi
from 43215
Reno, NV
Click here to add this to my saved trials
An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 Diabetes
A Multinational Observational Study Assessing Insulin Use: Understanding the Challenges Associated With Progression of Therapy - The MOSAIc Type 2 Diabetes Study
Status: Enrolling
Updated:  10/26/2015
Clinical Research Facility
330
mi
from 43215
Burlington, NC
An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 Diabetes
A Multinational Observational Study Assessing Insulin Use: Understanding the Challenges Associated With Progression of Therapy - The MOSAIc Type 2 Diabetes Study
Status: Enrolling
Updated: 10/26/2015
Clinical Research Facility
330
mi
from 43215
Burlington, NC
Click here to add this to my saved trials
An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 Diabetes
A Multinational Observational Study Assessing Insulin Use: Understanding the Challenges Associated With Progression of Therapy - The MOSAIc Type 2 Diabetes Study
Status: Enrolling
Updated:  10/26/2015
Clinical Research Facility
321
mi
from 43215
Greensboro, NC
An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 Diabetes
A Multinational Observational Study Assessing Insulin Use: Understanding the Challenges Associated With Progression of Therapy - The MOSAIc Type 2 Diabetes Study
Status: Enrolling
Updated: 10/26/2015
Clinical Research Facility
321
mi
from 43215
Greensboro, NC
Click here to add this to my saved trials
An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 Diabetes
A Multinational Observational Study Assessing Insulin Use: Understanding the Challenges Associated With Progression of Therapy - The MOSAIc Type 2 Diabetes Study
Status: Enrolling
Updated:  10/26/2015
Clinical Research Facility
300
mi
from 43215
Morganton, NC
An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 Diabetes
A Multinational Observational Study Assessing Insulin Use: Understanding the Challenges Associated With Progression of Therapy - The MOSAIc Type 2 Diabetes Study
Status: Enrolling
Updated: 10/26/2015
Clinical Research Facility
300
mi
from 43215
Morganton, NC
Click here to add this to my saved trials
An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 Diabetes
A Multinational Observational Study Assessing Insulin Use: Understanding the Challenges Associated With Progression of Therapy - The MOSAIc Type 2 Diabetes Study
Status: Enrolling
Updated:  10/26/2015
Clinical Research Facility
462
mi
from 43215
Tabor City, NC
An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 Diabetes
A Multinational Observational Study Assessing Insulin Use: Understanding the Challenges Associated With Progression of Therapy - The MOSAIc Type 2 Diabetes Study
Status: Enrolling
Updated: 10/26/2015
Clinical Research Facility
462
mi
from 43215
Tabor City, NC
Click here to add this to my saved trials
An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 Diabetes
A Multinational Observational Study Assessing Insulin Use: Understanding the Challenges Associated With Progression of Therapy - The MOSAIc Type 2 Diabetes Study
Status: Enrolling
Updated:  10/26/2015
Clinical Research Facility
217
mi
from 43215
Johnstown, PA
An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 Diabetes
A Multinational Observational Study Assessing Insulin Use: Understanding the Challenges Associated With Progression of Therapy - The MOSAIc Type 2 Diabetes Study
Status: Enrolling
Updated: 10/26/2015
Clinical Research Facility
217
mi
from 43215
Johnstown, PA
Click here to add this to my saved trials
An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 Diabetes
A Multinational Observational Study Assessing Insulin Use: Understanding the Challenges Associated With Progression of Therapy - The MOSAIc Type 2 Diabetes Study
Status: Enrolling
Updated:  10/26/2015
Clinical Research Facility
430
mi
from 43215
Levittown, PA
An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 Diabetes
A Multinational Observational Study Assessing Insulin Use: Understanding the Challenges Associated With Progression of Therapy - The MOSAIc Type 2 Diabetes Study
Status: Enrolling
Updated: 10/26/2015
Clinical Research Facility
430
mi
from 43215
Levittown, PA
Click here to add this to my saved trials
An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 Diabetes
A Multinational Observational Study Assessing Insulin Use: Understanding the Challenges Associated With Progression of Therapy - The MOSAIc Type 2 Diabetes Study
Status: Enrolling
Updated:  10/26/2015
Clinical Research Facility
527
mi
from 43215
Charleston, SC
An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 Diabetes
A Multinational Observational Study Assessing Insulin Use: Understanding the Challenges Associated With Progression of Therapy - The MOSAIc Type 2 Diabetes Study
Status: Enrolling
Updated: 10/26/2015
Clinical Research Facility
527
mi
from 43215
Charleston, SC
Click here to add this to my saved trials
An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 Diabetes
A Multinational Observational Study Assessing Insulin Use: Understanding the Challenges Associated With Progression of Therapy - The MOSAIc Type 2 Diabetes Study
Status: Enrolling
Updated:  10/26/2015
Clinical Research Facility
237
mi
from 43215
Kingsport, TN
An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 Diabetes
A Multinational Observational Study Assessing Insulin Use: Understanding the Challenges Associated With Progression of Therapy - The MOSAIc Type 2 Diabetes Study
Status: Enrolling
Updated: 10/26/2015
Clinical Research Facility
237
mi
from 43215
Kingsport, TN
Click here to add this to my saved trials
An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 Diabetes
A Multinational Observational Study Assessing Insulin Use: Understanding the Challenges Associated With Progression of Therapy - The MOSAIc Type 2 Diabetes Study
Status: Enrolling
Updated:  10/26/2015
Clinical Research Facility
910
mi
from 43215
Dallas, TX
An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 Diabetes
A Multinational Observational Study Assessing Insulin Use: Understanding the Challenges Associated With Progression of Therapy - The MOSAIc Type 2 Diabetes Study
Status: Enrolling
Updated: 10/26/2015
Clinical Research Facility
910
mi
from 43215
Dallas, TX
Click here to add this to my saved trials
An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 Diabetes
A Multinational Observational Study Assessing Insulin Use: Understanding the Challenges Associated With Progression of Therapy - The MOSAIc Type 2 Diabetes Study
Status: Enrolling
Updated:  10/26/2015
Clinical Research Facility
937
mi
from 43215
Ft.Worth, TX
An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 Diabetes
A Multinational Observational Study Assessing Insulin Use: Understanding the Challenges Associated With Progression of Therapy - The MOSAIc Type 2 Diabetes Study
Status: Enrolling
Updated: 10/26/2015
Clinical Research Facility
937
mi
from 43215
Ft.Worth, TX
Click here to add this to my saved trials
An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 Diabetes
A Multinational Observational Study Assessing Insulin Use: Understanding the Challenges Associated With Progression of Therapy - The MOSAIc Type 2 Diabetes Study
Status: Enrolling
Updated:  10/26/2015
Clinical Research Facility
1045
mi
from 43215
Georgetown, TX
An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 Diabetes
A Multinational Observational Study Assessing Insulin Use: Understanding the Challenges Associated With Progression of Therapy - The MOSAIc Type 2 Diabetes Study
Status: Enrolling
Updated: 10/26/2015
Clinical Research Facility
1045
mi
from 43215
Georgetown, TX
Click here to add this to my saved trials
An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 Diabetes
A Multinational Observational Study Assessing Insulin Use: Understanding the Challenges Associated With Progression of Therapy - The MOSAIc Type 2 Diabetes Study
Status: Enrolling
Updated:  10/26/2015
Clinical Research Facility
991
mi
from 43215
Houston, TX
An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 Diabetes
A Multinational Observational Study Assessing Insulin Use: Understanding the Challenges Associated With Progression of Therapy - The MOSAIc Type 2 Diabetes Study
Status: Enrolling
Updated: 10/26/2015
Clinical Research Facility
991
mi
from 43215
Houston, TX
Click here to add this to my saved trials
An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 Diabetes
A Multinational Observational Study Assessing Insulin Use: Understanding the Challenges Associated With Progression of Therapy - The MOSAIc Type 2 Diabetes Study
Status: Enrolling
Updated:  10/26/2015
Clinical Research Facility
896
mi
from 43215
Plano, TX
An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 Diabetes
A Multinational Observational Study Assessing Insulin Use: Understanding the Challenges Associated With Progression of Therapy - The MOSAIc Type 2 Diabetes Study
Status: Enrolling
Updated: 10/26/2015
Clinical Research Facility
896
mi
from 43215
Plano, TX
Click here to add this to my saved trials
An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 Diabetes
A Multinational Observational Study Assessing Insulin Use: Understanding the Challenges Associated With Progression of Therapy - The MOSAIc Type 2 Diabetes Study
Status: Enrolling
Updated:  10/26/2015
Clinical Research Facility
329
mi
from 43215
Alexandria, VA
An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 Diabetes
A Multinational Observational Study Assessing Insulin Use: Understanding the Challenges Associated With Progression of Therapy - The MOSAIc Type 2 Diabetes Study
Status: Enrolling
Updated: 10/26/2015
Clinical Research Facility
329
mi
from 43215
Alexandria, VA
Click here to add this to my saved trials
An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 Diabetes
A Multinational Observational Study Assessing Insulin Use: Understanding the Challenges Associated With Progression of Therapy - The MOSAIc Type 2 Diabetes Study
Status: Enrolling
Updated:  10/26/2015
Clinical Research Facility
341
mi
from 43215
Richmond, VA
An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 Diabetes
A Multinational Observational Study Assessing Insulin Use: Understanding the Challenges Associated With Progression of Therapy - The MOSAIc Type 2 Diabetes Study
Status: Enrolling
Updated: 10/26/2015
Clinical Research Facility
341
mi
from 43215
Richmond, VA
Click here to add this to my saved trials
An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 Diabetes
A Multinational Observational Study Assessing Insulin Use: Understanding the Challenges Associated With Progression of Therapy - The MOSAIc Type 2 Diabetes Study
Status: Enrolling
Updated:  10/26/2015
5386
mi
from 43215
Buenos Aires,
An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 Diabetes
A Multinational Observational Study Assessing Insulin Use: Understanding the Challenges Associated With Progression of Therapy - The MOSAIc Type 2 Diabetes Study
Status: Enrolling
Updated: 10/26/2015
5386
mi
from 43215
Buenos Aires,
Click here to add this to my saved trials
Evaluation of 18F-FP-DTBZ Pancreatic PET Scanning as a Tool to Measure Beta Cell Mass
Scan Re-Scan Pancreatic Beta Cell Imaging Using PET Imaging and 18F-FP-DTBZ
Status: Enrolling
Updated:  10/27/2015
Naomi Berrie Diabetes Center
442
mi
from 43215
New York, NY
Evaluation of 18F-FP-DTBZ Pancreatic PET Scanning as a Tool to Measure Beta Cell Mass
Scan Re-Scan Pancreatic Beta Cell Imaging Using PET Imaging and 18F-FP-DTBZ
Status: Enrolling
Updated: 10/27/2015
Naomi Berrie Diabetes Center
442
mi
from 43215
New York, NY
Click here to add this to my saved trials
Evaluation of the Precision of the Microperimetry Function of the Spectral OCT/SLO
Evaluation of the Precision of the Microperimetry Function of the Spectral OCT/SLO
Status: Enrolling
Updated:  10/28/2015
Retina Group of Florida
966
mi
from 43215
Fort Lauderdale, FL
Evaluation of the Precision of the Microperimetry Function of the Spectral OCT/SLO
Evaluation of the Precision of the Microperimetry Function of the Spectral OCT/SLO
Status: Enrolling
Updated: 10/28/2015
Retina Group of Florida
966
mi
from 43215
Fort Lauderdale, FL
Click here to add this to my saved trials
Evaluation of the Precision of the Microperimetry Function of the Spectral OCT/SLO
Evaluation of the Precision of the Microperimetry Function of the Spectral OCT/SLO
Status: Enrolling
Updated:  10/28/2015
Johns Hopkins Unversity
344
mi
from 43215
Baltimore, MD
Evaluation of the Precision of the Microperimetry Function of the Spectral OCT/SLO
Evaluation of the Precision of the Microperimetry Function of the Spectral OCT/SLO
Status: Enrolling
Updated: 10/28/2015
Johns Hopkins Unversity
344
mi
from 43215
Baltimore, MD
Click here to add this to my saved trials
Evaluation of the Precision of the Microperimetry Function of the Spectral OCT/SLO
Evaluation of the Precision of the Microperimetry Function of the Spectral OCT/SLO
Status: Enrolling
Updated:  10/28/2015
Valley Retina Institute, P.A.
1291
mi
from 43215
McAllen, TX
Evaluation of the Precision of the Microperimetry Function of the Spectral OCT/SLO
Evaluation of the Precision of the Microperimetry Function of the Spectral OCT/SLO
Status: Enrolling
Updated: 10/28/2015
Valley Retina Institute, P.A.
1291
mi
from 43215
McAllen, TX
Click here to add this to my saved trials
Retinal Blood Flow and Microthrombi in Type 1 Diabetes
Retinal Blood Flow and Microthrombi in Type 1 Diabetes
Status: Enrolling
Updated:  10/28/2015
Schepens Eye Research Institute
643
mi
from 43215
Boston, MA
Retinal Blood Flow and Microthrombi in Type 1 Diabetes
Retinal Blood Flow and Microthrombi in Type 1 Diabetes
Status: Enrolling
Updated: 10/28/2015
Schepens Eye Research Institute
643
mi
from 43215
Boston, MA
Click here to add this to my saved trials
OMT of Somatic Dysfunction and Chronic Low Back Pain in Patients With Type 2 Diabetes Mellitus
Osteopathic Manipulative Treatment of Somatic Dysfunction and Chronic Low Back Pain in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated:  10/29/2015
University of North Texas Health Science Center
939
mi
from 43215
Fort Worth, TX
OMT of Somatic Dysfunction and Chronic Low Back Pain in Patients With Type 2 Diabetes Mellitus
Osteopathic Manipulative Treatment of Somatic Dysfunction and Chronic Low Back Pain in Patients With Type 2 Diabetes Mellitus
Status: Enrolling
Updated: 10/29/2015
University of North Texas Health Science Center
939
mi
from 43215
Fort Worth, TX
Click here to add this to my saved trials
Evaluation of Biomarker Expression in Diabetic and Healthy Subjects Over a One Year Period
An Observational Study Evaluating Biomarker Expression in Diabetic and Healthy Subjects Over a One Year Period
Status: Enrolling
Updated:  10/29/2015
Novo Nordisk Clinical Trial Call Center
441
mi
from 43215
Princeton, NJ
Evaluation of Biomarker Expression in Diabetic and Healthy Subjects Over a One Year Period
An Observational Study Evaluating Biomarker Expression in Diabetic and Healthy Subjects Over a One Year Period
Status: Enrolling
Updated: 10/29/2015
Novo Nordisk Clinical Trial Call Center
441
mi
from 43215
Princeton, NJ
Click here to add this to my saved trials
A Study to Assess the Relative Bioavailability and to Assess the Effect of Food on the Bioavailability of a TAK-648 Tablet in Healthy Participants
A Phase 1, Randomized, Open-Label, Single-Dose, 3-Way Crossover Study to Assess the Relative Bioavailability of a TAK-648 Tablet Compared With a TAK-648 Oral Solution, and to Assess the Effect of Food on the Bioavailability of a TAK-648 Tablet in Healthy Participants
Status: Enrolling
Updated:  10/29/2015
Clinical Research Facility
1069
mi
from 43215
Austin, TX
A Study to Assess the Relative Bioavailability and to Assess the Effect of Food on the Bioavailability of a TAK-648 Tablet in Healthy Participants
A Phase 1, Randomized, Open-Label, Single-Dose, 3-Way Crossover Study to Assess the Relative Bioavailability of a TAK-648 Tablet Compared With a TAK-648 Oral Solution, and to Assess the Effect of Food on the Bioavailability of a TAK-648 Tablet in Healthy Participants
Status: Enrolling
Updated: 10/29/2015
Clinical Research Facility
1069
mi
from 43215
Austin, TX
Click here to add this to my saved trials
Diabetes Technology Study of Real-Time Glucose Alerts in the Team Management of Diabetes
Non-Significant Risk Investigational Device Study of the Wireless GlucoMON™ Glucose Meter Accessory and Real-time Blood Glucose Alerts as an Enabling Technology for People Who Team Manage Diabetes
Status: Enrolling
Updated:  10/30/2015
Diabetech
911
mi
from 43215
Dallas, TX
Diabetes Technology Study of Real-Time Glucose Alerts in the Team Management of Diabetes
Non-Significant Risk Investigational Device Study of the Wireless GlucoMON™ Glucose Meter Accessory and Real-time Blood Glucose Alerts as an Enabling Technology for People Who Team Manage Diabetes
Status: Enrolling
Updated: 10/30/2015
Diabetech
911
mi
from 43215
Dallas, TX
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of the Addition of Canagliflozin in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin
A Randomized, Double-blind, Placebo Controlled, 2-arm, Parallel-group, 26-week, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Canagliflozin in the Treatment of Subjects With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin Therapy
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
556
mi
from 43215
Montgomery, AL
A Study to Evaluate the Efficacy and Safety of the Addition of Canagliflozin in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin
A Randomized, Double-blind, Placebo Controlled, 2-arm, Parallel-group, 26-week, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Canagliflozin in the Treatment of Subjects With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin Therapy
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
556
mi
from 43215
Montgomery, AL
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of the Addition of Canagliflozin in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin
A Randomized, Double-blind, Placebo Controlled, 2-arm, Parallel-group, 26-week, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Canagliflozin in the Treatment of Subjects With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin Therapy
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
1662
mi
from 43215
Phoenix, AZ
A Study to Evaluate the Efficacy and Safety of the Addition of Canagliflozin in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin
A Randomized, Double-blind, Placebo Controlled, 2-arm, Parallel-group, 26-week, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Canagliflozin in the Treatment of Subjects With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin Therapy
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
1662
mi
from 43215
Phoenix, AZ
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of the Addition of Canagliflozin in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin
A Randomized, Double-blind, Placebo Controlled, 2-arm, Parallel-group, 26-week, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Canagliflozin in the Treatment of Subjects With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin Therapy
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
1662
mi
from 43215
Phoenix, AZ
A Study to Evaluate the Efficacy and Safety of the Addition of Canagliflozin in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin
A Randomized, Double-blind, Placebo Controlled, 2-arm, Parallel-group, 26-week, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Canagliflozin in the Treatment of Subjects With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin Therapy
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
1662
mi
from 43215
Phoenix, AZ
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of the Addition of Canagliflozin in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin
A Randomized, Double-blind, Placebo Controlled, 2-arm, Parallel-group, 26-week, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Canagliflozin in the Treatment of Subjects With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin Therapy
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
622
mi
from 43215
Little Rock, AR
A Study to Evaluate the Efficacy and Safety of the Addition of Canagliflozin in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin
A Randomized, Double-blind, Placebo Controlled, 2-arm, Parallel-group, 26-week, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Canagliflozin in the Treatment of Subjects With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin Therapy
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
622
mi
from 43215
Little Rock, AR
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of the Addition of Canagliflozin in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin
A Randomized, Double-blind, Placebo Controlled, 2-arm, Parallel-group, 26-week, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Canagliflozin in the Treatment of Subjects With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin Therapy
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
1982
mi
from 43215
Northridge, CA
A Study to Evaluate the Efficacy and Safety of the Addition of Canagliflozin in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin
A Randomized, Double-blind, Placebo Controlled, 2-arm, Parallel-group, 26-week, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Canagliflozin in the Treatment of Subjects With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin Therapy
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
1982
mi
from 43215
Northridge, CA
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of the Addition of Canagliflozin in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin
A Randomized, Double-blind, Placebo Controlled, 2-arm, Parallel-group, 26-week, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Canagliflozin in the Treatment of Subjects With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin Therapy
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
1967
mi
from 43215
Norwalk, CA
A Study to Evaluate the Efficacy and Safety of the Addition of Canagliflozin in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin
A Randomized, Double-blind, Placebo Controlled, 2-arm, Parallel-group, 26-week, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Canagliflozin in the Treatment of Subjects With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin Therapy
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
1967
mi
from 43215
Norwalk, CA
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of the Addition of Canagliflozin in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin
A Randomized, Double-blind, Placebo Controlled, 2-arm, Parallel-group, 26-week, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Canagliflozin in the Treatment of Subjects With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin Therapy
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
1935
mi
from 43215
Rancho Cucamonga, CA
A Study to Evaluate the Efficacy and Safety of the Addition of Canagliflozin in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin
A Randomized, Double-blind, Placebo Controlled, 2-arm, Parallel-group, 26-week, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Canagliflozin in the Treatment of Subjects With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin Therapy
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
1935
mi
from 43215
Rancho Cucamonga, CA
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of the Addition of Canagliflozin in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin
A Randomized, Double-blind, Placebo Controlled, 2-arm, Parallel-group, 26-week, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Canagliflozin in the Treatment of Subjects With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin Therapy
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
2083
mi
from 43215
San Ramon, CA
A Study to Evaluate the Efficacy and Safety of the Addition of Canagliflozin in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin
A Randomized, Double-blind, Placebo Controlled, 2-arm, Parallel-group, 26-week, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Canagliflozin in the Treatment of Subjects With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin Therapy
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
2083
mi
from 43215
San Ramon, CA
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of the Addition of Canagliflozin in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin
A Randomized, Double-blind, Placebo Controlled, 2-arm, Parallel-group, 26-week, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Canagliflozin in the Treatment of Subjects With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin Therapy
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
1154
mi
from 43215
Aurora, CO
A Study to Evaluate the Efficacy and Safety of the Addition of Canagliflozin in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin
A Randomized, Double-blind, Placebo Controlled, 2-arm, Parallel-group, 26-week, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Canagliflozin in the Treatment of Subjects With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin Therapy
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
1154
mi
from 43215
Aurora, CO
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of the Addition of Canagliflozin in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin
A Randomized, Double-blind, Placebo Controlled, 2-arm, Parallel-group, 26-week, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Canagliflozin in the Treatment of Subjects With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin Therapy
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
1162
mi
from 43215
Denver, CO
A Study to Evaluate the Efficacy and Safety of the Addition of Canagliflozin in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin
A Randomized, Double-blind, Placebo Controlled, 2-arm, Parallel-group, 26-week, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Canagliflozin in the Treatment of Subjects With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin Therapy
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
1162
mi
from 43215
Denver, CO
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of the Addition of Canagliflozin in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin
A Randomized, Double-blind, Placebo Controlled, 2-arm, Parallel-group, 26-week, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Canagliflozin in the Treatment of Subjects With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin Therapy
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
1164
mi
from 43215
Littleton, CO
A Study to Evaluate the Efficacy and Safety of the Addition of Canagliflozin in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin
A Randomized, Double-blind, Placebo Controlled, 2-arm, Parallel-group, 26-week, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Canagliflozin in the Treatment of Subjects With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin Therapy
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
1164
mi
from 43215
Littleton, CO
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of the Addition of Canagliflozin in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin
A Randomized, Double-blind, Placebo Controlled, 2-arm, Parallel-group, 26-week, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Canagliflozin in the Treatment of Subjects With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin Therapy
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
973
mi
from 43215
Cooper City, FL
A Study to Evaluate the Efficacy and Safety of the Addition of Canagliflozin in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin
A Randomized, Double-blind, Placebo Controlled, 2-arm, Parallel-group, 26-week, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Canagliflozin in the Treatment of Subjects With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin Therapy
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
973
mi
from 43215
Cooper City, FL
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of the Addition of Canagliflozin in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin
A Randomized, Double-blind, Placebo Controlled, 2-arm, Parallel-group, 26-week, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Canagliflozin in the Treatment of Subjects With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin Therapy
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
993
mi
from 43215
Miami, FL
A Study to Evaluate the Efficacy and Safety of the Addition of Canagliflozin in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin
A Randomized, Double-blind, Placebo Controlled, 2-arm, Parallel-group, 26-week, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Canagliflozin in the Treatment of Subjects With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin Therapy
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
993
mi
from 43215
Miami, FL
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of the Addition of Canagliflozin in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin
A Randomized, Double-blind, Placebo Controlled, 2-arm, Parallel-group, 26-week, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Canagliflozin in the Treatment of Subjects With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin Therapy
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
993
mi
from 43215
Miami, FL
A Study to Evaluate the Efficacy and Safety of the Addition of Canagliflozin in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin
A Randomized, Double-blind, Placebo Controlled, 2-arm, Parallel-group, 26-week, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Canagliflozin in the Treatment of Subjects With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin Therapy
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
993
mi
from 43215
Miami, FL
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of the Addition of Canagliflozin in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin
A Randomized, Double-blind, Placebo Controlled, 2-arm, Parallel-group, 26-week, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Canagliflozin in the Treatment of Subjects With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin Therapy
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
983
mi
from 43215
North Miami Beach, FL
A Study to Evaluate the Efficacy and Safety of the Addition of Canagliflozin in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin
A Randomized, Double-blind, Placebo Controlled, 2-arm, Parallel-group, 26-week, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Canagliflozin in the Treatment of Subjects With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin Therapy
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
983
mi
from 43215
North Miami Beach, FL
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of the Addition of Canagliflozin in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin
A Randomized, Double-blind, Placebo Controlled, 2-arm, Parallel-group, 26-week, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Canagliflozin in the Treatment of Subjects With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin Therapy
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
436
mi
from 43215
Atlanta, GA
A Study to Evaluate the Efficacy and Safety of the Addition of Canagliflozin in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin
A Randomized, Double-blind, Placebo Controlled, 2-arm, Parallel-group, 26-week, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Canagliflozin in the Treatment of Subjects With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin Therapy
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
436
mi
from 43215
Atlanta, GA
Click here to add this to my saved trials
A Study to Evaluate the Efficacy and Safety of the Addition of Canagliflozin in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin
A Randomized, Double-blind, Placebo Controlled, 2-arm, Parallel-group, 26-week, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Canagliflozin in the Treatment of Subjects With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin Therapy
Status: Enrolling
Updated:  11/2/2015
Clinical Research Facility
519
mi
from 43215
Perry, GA
A Study to Evaluate the Efficacy and Safety of the Addition of Canagliflozin in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin
A Randomized, Double-blind, Placebo Controlled, 2-arm, Parallel-group, 26-week, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Canagliflozin in the Treatment of Subjects With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin Therapy
Status: Enrolling
Updated: 11/2/2015
Clinical Research Facility
519
mi
from 43215
Perry, GA
Click here to add this to my saved trials